Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study ; volume:14 ; number:1 ; day:9 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Translational Psychiatry ; 14, Heft 1 (9.9.2024), 1-11, 12.2024
- Urheber
-
Daniilidou, Makrina
Holleman, Jasper
Hagman, Göran
Kåreholt, Ingemar
Aspö, Malin
Brinkmalm, Ann
Zetterberg, Henrik
Blennow, Kaj
Solomon, Alina
Kivipelto, Miia
Sindi, Shireen
Matton, Anna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41398-024-03072-x
- URN
-
urn:nbn:de:101:1-2411232127386.483910276438
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Daniilidou, Makrina
- Holleman, Jasper
- Hagman, Göran
- Kåreholt, Ingemar
- Aspö, Malin
- Brinkmalm, Ann
- Zetterberg, Henrik
- Blennow, Kaj
- Solomon, Alina
- Kivipelto, Miia
- Sindi, Shireen
- Matton, Anna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery—a randomized trial
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery—a randomized trial
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery—a randomized trial